|
Press Releases |
|
 |
|
Wednesday, April 24, 2024 |
|
NEC Develops High-speed Generative AI Large Language Models (LLM) with World-class Performance |
NEC Corporation has expanded its "NEC cotomi" generative AI services with the development of "NEC cotomi Pro" and "NEC cotomi Light," two new high-speed generative AI Large Language Models (LLM) featuring updated training data and architectures. more info >> |
|
Monday, April 22, 2024 |
|
NEC Strengthens Commitment to Space Industry with Investment in Seraphim Space Venture Fund II |
NEC Corporation (NEC; TSE: 6701) today announced a strategic investment in "Seraphim Space Venture Fund II," a pioneering venture capital fund specializing in the space industry and operated by Seraphim Space, the most prolific investor globally in this domain. more info >> |
|
Tuesday, April 16, 2024 |
|
NEC、SBTiからNet-Zero目標の認定を取得 |
NECは、SBTi(The Science Based Targets initiative、注1)からNet-Zero目標の認定を取得しました。 more info >> |
|
Thursday, April 11, 2024 |
|
DOCOMO, NTT, NEC and Fujitsu Develop Top-level Sub-terahertz 6G Device Capable of Ultra-high-speed 100 Gbps Transmission |
NTT DOCOMO, INC., NTT Corporation, NEC Corporation and Fujitsu Limited jointly announced today the development of a top-level (1) wireless device capable of ultra-high-speed 100 Gbps transmissions in the 100 GHz and 300 GHz sub-terahertz bands. more info >> |
|
Wednesday, April 10, 2024 |
|
Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024 |
Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Corporation, a leader in IT, network and AI technologies, announced that new data will be presented on TG4050, an individualized neoantigen cancer vaccine, at the American Association for Cancer Research (AACR) Annual Meeting in San Diego, CA. more info >> |
|
Monday, April 8, 2024 |
|
NEC white paper proposes comprehensive process workflow for the application of AI-driven personalized cancer vaccines |
NEC Corporation (TSE: 6701) has released a white paper, "Towards the realization of AI drug development: Comprehensive process workflow for the commercial use of personalized cancer vaccines". more info >> |
|
Monday, March 25, 2024 |
|
NEC develops marketing strategy planning & effectiveness simulation technology using generative AI |
NEC Corporation (TSE: 6701) has developed a marketing strategy planning & effectiveness simulation technology that utilizes generative AI to identify latent needs of customers and generate optimal measures. more info >> |
|
Friday, March 22, 2024 |
|
NEC and NTT successfully conduct first-of-its-kind long-distance transmission experiment over 7,000km using 12-core optical fiber |
NEC Corporation (TSE: 6701) and NTT Corporation (NTT) today announced that they have successfully conducted a first-of-its-kind transoceanic-class 7,280km transmission experiment using a coupled 12-core multicore fiber(1), which consists of 12 optical signal transmission paths in a standard outer diameter optical fiber (0.125 mm). more info >> |
|
Tuesday, June 1, 2021 |
|
NECと東京医科歯科大学、ヘルスケアサービス「NECカラダケア」の実証事業を開始 |
日本電気株式会社(代表取締役 執行役員社長 兼 CEO:森田 隆之、以下 NEC)と国立大学法人東京医科歯科大学(学長:田中 雄二郎、以下 TMDU)は、本年6月からヘルスケアサービス「NECカラダケア」の実証事業を開始します。本実証事業の第一弾として、NECカラダケア神楽坂店をオープンし、一人ひとりの健康状態に合わせた身体のケアを支援する「フィジカルケア」のサービスを6月15日から提供開始します。 more info >> |
|
Monday, May 31, 2021 |
|
量子技術を活用した新産業の創出に向けて「量子技術による新産業創出協議会」の設立発起人会を開催 |
量子技術による社会構造変革を目指す民間企業11社(以下に記載)は、本日、業界の垣根を越えて、量子技術を応用した新産業の創出を図るための協議会、「量子技術による新産業創出協議会」(以下、本協議会)の設立発起人会を開催しました。今後、企業や専門家に対し、本協議会への参画を募るなど、今夏の設立に向けた具体的な準備を進めてまいります。 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
U.S. Polo Assn. Returns as Official Apparel and Jersey Partner for Chestertons Polo in the Park in Downtown London
Jun 10, 2025 23:27 HKT/SGT
|
|
|
New HKTDC Chairman Frederick Ma keen to promote Hong Kong as best partner for global enterprises
Jun 10, 2025 22:28 HKT/SGT
|
|
|
爆款IPO前瞻:「香水第一股」穎通控股強勢登場!港股IPO再現黃金賽道 龍頭勢掀「嗅覺經濟」新浪潮
Jun 10, 2025 19:10 HKT/SGT
|
|
|
爆款IPO前瞻:“香水第一股”颖通控股强势登场!港股IPO再现黄金赛道 龙头势掀“嗅觉经济”新浪潮
Jun 10, 2025 19:10 HKT/SGT
|
|
|
Supercomputer Fugaku retains first place worldwide in Graph500 rankings
Jun 10, 2025 19:47 JST
|
|
|
ダイムラートラック、三菱ふそう、日野、トヨタ、三菱ふそうと日野の統合に関する最終合意を締結
Jun 10, 2025 16:30: JST
|
|
|
聯想控股副總裁于浩:在技術變革中錨定「長期主義」
Jun 10, 2025 15:37 HKT/SGT
|
|
|
联想控股副总裁于浩:在技术变革中锚定"长期主义"
Jun 10, 2025 15:28 HKT/SGT
|
|
|
Ai sẽ là người đầu tiên ghi danh vào lịch sử với tư cách là Nhà Vô Địch Thế Giới đầu tiên?!
Jun 10, 2025 14:00 HKT/SGT
|
|
|
Siapakah yang akan mengukir nama dalam sejarah sebagai "Juara Dunia Pertama"!
Jun 10, 2025 14:00 HKT/SGT
|
|
|
Siapakah yang akan mengukir namanya dalam sejarah sebagai “Juara Dunia Pertama”!
Jun 10, 2025 14:00 HKT/SGT
|
|
|
誰將成為名留青史的「初代世界冠軍」!
Jun 10, 2025 14:00 HKT/SGT
|
|
|
UK MOD Signs Protector Support Contract with GA-ASI
Jun 10, 2025 06:00 HKT/SGT
|
|
|
SRKay Consulting Group Releases Research Report: 'From Legal Frameworks to Successful Operations'--A Strategic Playbook for India Market Entry
Jun 9, 2025 17:00 HKT/SGT
|
|
|
Everest Medicines Presents Positive Results from Phase 1b/2a Clinical Trial of EVER001 for Primary Membranous Nephropathy at ERA 2025
Jun 9, 2025 12:52 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|